1573 results for Treatments

Refine Your Search

Exploring Blood Cancer Treatments and Support

Join us for a free, education program for the blood cancer community. Registration is required.About the programPatients, survivors, caregivers, love…

Accelerating new treatments for pediatric patients

Accelerating new treatments for pediatric patients

When it comes to childhood cancers, regulators often approach kids as if they’re tiny adults. But the biology of pediatric cancers is typically distin…

Advocacy

New Insights & Treatments for Leukemia

New Insights & Treatments for Leukemia To register or For more information, please contact Mary Walls, Patient Access Manager, mary.wal…

Continued Collaboration Fuels Hope for Rare Blood Cancer Treatments

Continued Collaboration Fuels Hope for Rare Blood Cancer Treatments

The Hairy Cell Leukemia Foundation (HCLF) and The Leukemia & Lymphoma Society, now Blood Cancer United, have renewed their partnership to support the …

News Release

Latest FDA Approval Joins a Torrent of New Treatments for Aggressive Lymphoma Subtype

Latest FDA Approval Joins a Torrent of New Treatments for Aggressive Lymphoma Subtype

Rye Brook, N.Y., July , – The U.S. Food and Drug Administration (FDA) recently approved (Columvi™) to treat adults with diffuse large lymphoma (DLB…

News Release

Creating Safe and Effective Cancer Treatments: FDA Approval Process for Cancer Drugs

By Abby Henry, Oncology Content Manager, PearlPoint Cancer Support

News Release

Evaluating a novel collaboration between NOTCH1 and MLL1 for improved targeted treatments in T-ALL

Most T cell acute lymphoblastic leukemia () patients respond to chemotherapy, however many relapse with limited therapy options. To address this probl…

Valvoline™ Global Operations Announces Major Commitment to              The Leukemia & Lymphoma Society to Power Better Treatments for Kids with Blood Cancer Worldwide

Valvoline™ Global Operations Announces Major Commitment to The Leukemia & Lymphoma Society to Power Better Treatments for Kids with Blood Cancer Worldwide

LEXINGTON, KY & RYE BROOK, NY, SEPTEMBER , – Valvoline Global Operations, a worldwide leader in automotive and industrial solutions creating product…

Another Option: Clinical Trials

Another Option: Clinical Trials

A blood cancer diagnosis typically leads one to an oncologist or hematologist, a cancer center and a conversation about available treatment options. O…

Seven Insights for Better Nutrition During Cancer Treatment

In the New Year, you may be looking to turn over a new leaf. One goal may be to improve your nutrition. Many cancer survivors struggle with food issue…

Another First: FDA Approves Car T-Immunotherapy for Treatment of Aggressive Form of Indolent Non-Hodgkin Lymphoma

The U.S. Food and Drug Administration (FDA) today approved the CAR treatment axicabtagene ciloleucel (Yescarta®) for patients with follicular lymphom…

After Cancer Treatment: When Going Back to School isn’t Exciting

More than , children are affected by leukemia and lymphoma each year. These blood cancers account for about percent of all childhood cancers. Fortun…

Heart Disease in Lymphoma Survivors

Matthew Matasar is a hematology and oncology specialist at Memorial Cancer Center in New York City. He has a Translational Research Program grant thr…

LLS advocates helped North Carolina expand Medicaid

North Carolina Gov. Roy Cooper just signed Medicaid expansion into law, following years of advocacy from LLS volunteers and staff. Once it takes effec…

Highlights from ASCO 2021

Highlights from ASCO 2021

The American Society of Clinical Oncology (ASCO) Annual Meeting took place last week. ASCO brings together the cancer community to explore the latest…

New Drug Approval Moves Us Closer To Long-Term Control of Multiple Myeloma

Just one year after the first CAR treatment was approved for multiple myeloma, the second is about to hit the market. The FDA approved ciltacabtagene…

Blood Cancer Research Poised for Another ‘Banner Year’ in 2024

Blood Cancer Research Poised for Another ‘Banner Year’ in 2024

More than , medical professionals from across the world came together in December to discuss the latest blood cancer developments during the annual me…

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Lymphoma diagnosis, survival rate by age, prognosis, and treatment

Table of contents:What is Hodgkin lymphoma? Organs affected by Hodgkin lymphomaHodgkin lymphoma symptoms and early signsWhat is lymphoma?Organs affec…

We Dare to Dream so Their Dreams Come True

We Dare to Dream so Their Dreams Come True

Did you know that blood cancer is the most common cancer diagnosis for children, accounting for % of pediatric cancer cases? In fact, nearly , childre…

The Immune System and Blood Cancer: 4 Things You Need to Know

The Immune System and Blood Cancer: 4 Things You Need to Know

Immunotherapy uses the power of the immune system to treat blood cancer. Today it is a standard treatment that has a profound effect in some blood can…

“Stages” of Leukemia: Understanding Classification and Progression

“Stages” of Leukemia: Understanding Classification and Progression

Table of contentsStages of Leukemia Chronic Lymphocytic Leukemia (CLL) Acute Lymphoblastic Leukemia (ALL) Acute Myeloid Leukemia (AML) Chronic Mye…

What causes acute myeloid leukemia?

What causes acute myeloid leukemia?

Table of contents: What causes acute myeloid leukemia?What is AML?Role of bone marrow and white blood cellsHow leukemia interferes with blood cell cou…

Understanding AML vs. ALL: Navigating the complex field

Understanding AML vs. ALL: Navigating the complex field

Table of contents: Understanding AML vs. ALL: Navigating the complex fieldSimilarities and differences between AML and ALLCauses and risk factors: Und…